trapidil and Pre-Eclampsia studies

trapidil and Pre-Eclampsia

trapidil has been researched along with Pre-Eclampsia in 3 studies

Trapidil: A coronary vasodilator agent.

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research Excerpts

Excerpt	Relevance	Reference
"Trapidil was associated with an about twofold increase of 6-keto PGF1 alpha concentration in the peripheral venous blood, while the concentration of thromboxane A2 revealed no changes."	6.68	[Effect of trapidil in prevention of pre-eclampsia and fetal retardation]. ( Augustin, W; Claus, P; Nieder, J, 1995)
"Trapidil was associated with an about twofold increase of 6-keto PGF1 alpha concentration in the peripheral venous blood, while the concentration of thromboxane A2 revealed no changes."	2.68	[Effect of trapidil in prevention of pre-eclampsia and fetal retardation]. ( Augustin, W; Claus, P; Nieder, J, 1995)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (33.33)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Dodd, JM	2
McLeod, A	2
Windrim, RC	2
Kingdom, J	2
Nieder, J	1
Claus, P	1
Augustin, W	1

Studies

Dodd, JM

McLeod, A

Windrim, RC

Kingdom, J

Nieder, J

Claus, P

Augustin, W

Reviews

2 reviews available for trapidil and Pre-Eclampsia

Article	Year
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. The Cochrane database of systematic reviews, 2013, Jul-24, Issue:7 Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low	2013
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. The Cochrane database of systematic reviews, 2010, Jun-16, Issue:6 Topics: Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Wei	2010

Article

Year

Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.

The Cochrane database of systematic reviews, 2013, Jul-24, Issue:7

Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low

2013

Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.

The Cochrane database of systematic reviews, 2010, Jun-16, Issue:6

Topics: Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Wei

2010

Trials

1 trial available for trapidil and Pre-Eclampsia

Article	Year
[Effect of trapidil in prevention of pre-eclampsia and fetal retardation]. Zentralblatt fur Gynakologie, 1995, Volume: 117, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Double-Blind Method; Female; Fetal Growth Retardati	1995

Article

Year

[Effect of trapidil in prevention of pre-eclampsia and fetal retardation].

Zentralblatt fur Gynakologie, 1995, Volume: 117, Issue:1

Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Double-Blind Method; Female; Fetal Growth Retardati

1995